Hôpital Pellegrin, Bordeaux, FRANCE Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03345953
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CHU Bordeaux Pellegrin | CIC SANPSY (USR CNRS 3413), Groupe Hospitalier Pellegrin, Bordeaux, France | CIC SANPSY (USR CNRS 3413), Hôpital Pellegrin, Bordeaux, FRANCE | Hôpital Pellegrin